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mplantation of the in situ internal thoracic artery
raft in patients scheduled for surgical myocardial
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meripheral vascular atherosclerotic distributions involving
especially the supra-aortic vessels are quite prevale1
As a result, in patients with multivessel coronary disease
including the left anterior descending (LAD) coronary
rtery, the left internal thoracic artery (ITA) may not be suitable as an
rterial conduit because of left subclavian artery (LSA) stenosis. In
uch cases the alternatives are to implant a skeletonized left or right
TA graft (LITA or RITA graft), a radial artery, or a saphenous vein
raft: unfortunately, all these options have a worse long-term pa-
ency rate than use of the in situ LITA.2 To improve long-term
atency rate, especially in relatively young patients, the in situ
ITA can be made suitable as an arterial conduit by angioplasty
nd stenting of the LSA. We sought to present our preliminary
xperience of LSA stenting to make the LITA suitable as an
rterial conduit in patients with stenosis of the LSA scheduled for
urgical revascularization.
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ABLE 1. Clinical and procedural data of the patients
atient
Age
(y) CAD Risk factors EF (%) Clinical
1 54 LM, RCA HPT, HY, SM 58 ACS, prev
2 50 LM, LCX, MO HPT, HY, SM 68 Recent A
3 47 LM, LCX, RCA DB, HP, HY 74 Recent A
4 64 LM, RCA HPT, HY 51 Recent A
CS, Non–ST-elevation acute coronary syndrome; AMI, acute myocardial infa
y angiography; HPT, hypertension; HY, hypercholesterolemia; LAD, left anter
SA, left subclavian artery; MO, obtuse marginal; RCA, right coronary artery; SM, s
The Journal of Thoracethods
etween November 2004 and
anuary 2006, four consecutive
atients scheduled for urgent coronary surgery underwent LSA an-
ioplasty and stenting to make the ITA suitable as an arterial conduit
Table 1). Indications for coronary surgery rather than multives
ercutaneous coronary interventions were based on left main dis-
ase or complex LAD disease and young (60 years) age. In-
ormed consent was obtained from all patients. LSA stenting was
erformed via the right femoral approach with a standard Judkins
ight or multipurpose 6F guiding catheter with a hydrophilic 0.018-
nch guidewire to deploy a balloon-expandable Genesis (Cordis
nc, Johnson & Johnson, Warren, NJ) endovascular stent (Fi
). No protection filter device was used because no patient
igns of previous cholesterolemic embolization. After the proce-
ure, aspirin (100 mg/day) plus low molecular weight heparin
nadroparin calcium) 100 IU · kg1 · 12 h1 were administered
ntil the coronary surgical revascularization (usually 72 hours).
Follow-up was accomplished by 3-, 6-, and 12-month visits and
- and 12-month stress tests (treadmill test or nuclear stress test).
urveillance of the implanted stent was performed by 6- and
2-month Doppler ultrasonography examination or angiography
ith magnetic resonance imaging.
esults
he procedure was successful in all patients: no cerebral or pe-
ipheral embolism was noted after angioplasty and stenting of the
SA (Table 1). Troponin T and creatine kinase-MB remaine
asal levels after the procedure in all patients despite one patient
aving anginal symptoms with transitory electrocardiographic
yocardial ischemia requiring nitrate infusion. All four patients
ry
Indications to
intervention
Stent (dimeter 
length mm)
Final stent
diameter (mm)
TIA 80% LSA stenosis Genesis (6  29 mm) 7.10
LI 99% LSA stenosis Genesis (7  29 mm) 8.05
80% LSA stenosis Genesis (7  39 mm) 8.20
LI 99% LSA stenosis Genesis (7  39 mm) 8.10
; CAD, coronary artery disease; DB, diabetes; EF, ejection fraction evaluated
scending coronary artery; LCX, left circumflex coronary artery; LM, left main;
Dr Rigatellihisto
ious
MI, U
CS
CS, U
rction
ior demoking; TIA, transient ischemic attack
ic and Cardiovascular Surgery; ULI, upper limb ischemia.
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enderwent successful coronary surgery with the LITA as in situ
rterial conduit after 1, 2, 3, and 1 days, respectively: no patients
ad a cerebral ischemic attack in the preoperative period or acute
imb ischemia; no patients died intraoperatively or perioperatively.
t a mean follow-up of 6  4.6 months, all patients are alive and
ree from angina and residual induced ischemia. On clinical and
nstrumental examination, no evident thrombosis or restenosis has
een documented in the implanted vascular stents.
iscussion
n case of LSA stenosis, the LITA is not suitable as in situ arterial
onduit and the alternatives are to use a skeletonized LITA or
ITA, a radial artery, or the standard saphenous vein graft. Un-
ortunately, these options have a low patency rate. In a recent
eview, the calculated long-term patency rate was 95.9% for the
ITA, 91.2% for the RITA, 90.6% for the radial artery, and 81.8%
or the saphenous vein. Moreover, the patency rate differs signif-
cantly also between the in situ LITA and free-graft LITA: 96.3%
ersus 86.5% at 5 years.3
A not yet fully investigated option is to perform an angioplasty
nd stenting of the LSA to prevent any subclavian or coronary
teal syndrome and make the ITA suitable as an arterial conduit.
SA angioplasty and stenting is a safe and effective procedure
ith a primary clinical patency rate at 5 years of 89%, a local
omplication rate of 4.5%, and a combined stroke and death rate of
.6%.4 The procedure is lasting, as demonstrated by De Vries
ssociates5: all clinical failures usually occur within 26 months
10 The Journal of Thoracic and Cardiovascular Surgery ● Junefter initial therapy, suggesting a regular follow-up for at least 2
ears after percutaneous transluminal angioplasty.5
Although our very small series of patients can be considered
necdotal, it suggests that LSA angioplasty may be effective in
aking the LITA suitable as an arterial conduit. This strategy may
e useful especially in young patients in whom the use of in situ
ITA guarantees the best long-term patency rate. The proposed
light” antiplatelet regimen was well tolerated with no adverse
vents in terms of thrombotic or hemorrhagic effects.
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